We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-6.00 | -0.30% | 2,006.00 | 2,004.00 | 2,008.00 | 2,024.00 | 1,996.00 | 2,014.00 | 24,247 | 10:00:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 23.10 | 4.43B |
Date | Subject | Author | Discuss |
---|---|---|---|
05/1/2022 12:10 | That’s about a month late! | blue59 | |
28/12/2021 12:01 | Yes not a income stock, dividend growing every year, more a growth stock. | montyhedge | |
24/12/2021 12:06 | Hikma dividend too low in present environment with so many high yielders at good prices. | cumnor | |
24/12/2021 11:56 | Health care budgets taken up with Covid? | robertball | |
24/12/2021 09:24 | Down 20% from high, others in the pharmaceutical sector performing well, so Hikma is like Cinderella of the sector, figures we know will be good, looking at the trading statement, also will be 16 years of continuous dividend growth, we can't ask for much more. | montyhedge | |
23/12/2021 18:40 | Nope, what is it we don’t know? | woodyjmw | |
23/12/2021 14:11 | Even Santa can't make Hikma rally.Very sad. | brain smiley | |
22/12/2021 09:43 | Down 20% from this years high, certainly missed out on the pharmaceutical sector which had a good run. Cheapest of all the pharma sector, but seems the Cinderella of the sector. | montyhedge | |
20/12/2021 21:21 | I agree momentum and money flow index indicators are increasing, also price is at a support level from March, so hope for a bounce here, unless the rest of the market sinks. | woodyjmw | |
17/12/2021 14:56 | We know the figures are going to be superb, looking at the trading statement, another dividend increase of course expected, that's 15 years on the trot, not bad for a so called boring safe company.Not a trading share for me, bottom draw, look every now and then. | montyhedge | |
16/12/2021 15:23 | Odd share performance - very weak. Chart looks dodgy - double top below 2180 ? If directors would buy here, I would as well for a trade. | brain smiley | |
16/12/2021 14:22 | There they go again, todays rns, lol. | montyhedge | |
13/12/2021 13:24 | Like Buffett said the market is a voting machine, but in the end it's a weighing machine, if other words when the figures come out and they are good, re-rating. | montyhedge | |
11/12/2021 07:48 | The market can be irrational. Value comes out in the end. Hold | robertball | |
10/12/2021 11:24 | Agree, very strange, trading update superb. Lowest p.e in the pharma sector, dividend growth for years.But it's unloved. | montyhedge | |
10/12/2021 10:07 | I just can’t understand why this company is so unloved. It seems a good sound company.any ideas why the price keeps going down?. Thank you. | hopefuldave | |
09/12/2021 16:20 | One thing, weak pound helps dollar earners, bigger dividends for us. | montyhedge | |
09/12/2021 11:28 | Another good rns today, market takes no notice. | montyhedge | |
06/12/2021 08:20 | Great price you paid, we know the figures are going to be superb from the trading update, 15 years of continuous dividend growth, looks like 16 coming. These should be 2800p. | montyhedge | |
03/12/2021 12:56 | Looks like they sell, price comes down, then buy shares go back up. I suppose by doing that they end up with more shares but cheaper at the end of the day. | montyhedge | |
03/12/2021 08:19 | Only time will tell ! | blue59 | |
02/12/2021 13:21 | Blackrock buying back | scepticalinvestor | |
02/12/2021 12:20 | Looks like they been selling all the way down from 2700p, it was a superb trading statement, perhaps they will be buyers again at 2100p. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions